UK markets open in 5 hours 8 minutes

Iovance Biotherapeutics, Inc. (0JDK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
26.61+1.10 (+4.32%)
At close: 5:22PM BST
Full screen
Loading interactive chart…
  • Zacks

    Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 49% as Wall Street Analysts Expect?

    The consensus price target hints at a 49% upside potential for Iovance Biotherapeutics (IOVA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • Motley Fool

    Why Iovance Is Up Nearly 11% Today

    Shares of biopharma company Iovance (NASDAQ: IOVA) are poised to end Wednesday's trading session almost 11% higher than Tuesday's close, following an encouraging observation from investment analytics outfit Truist. Namely, the odds of an approval of one of its drug prospects seemingly improved after a rival drug developer was granted permission to expand its trials of a similar therapy. On Monday, Instil Bio (NASDAQ: TIL) announced the Food and Drug Administration had cleared the company's request to widen the scope of its current phase 2 trial of ITIL-168.

  • Zacks

    Implied Volatility Surging for Iovance (IOVA) Stock Options

    Investors need to pay close attention to Iovance (IOVA) stock based on the movements in the options market lately.